LHV finantsportaal

Foorum Investeerimine

Börsipäev 13.veebruar

Kommentaari jätmiseks loo konto või logi sisse

  • Uut nädalat alustasid Balti börsiindeksid plusspoolel - Tallinn +0.18%, Riia +0.18%, Vilnius +1.25%. Käibeks kujunes 369 tehinguga 539 tuhat eurot, millest Tallinna börsi käive moodustas 195 tehinguga 260 tuhat eurot ning Viniuse börsi käive 134 tehinguga 233 tuhat eurot.

    Enimkaubeldud aktsia oli Šiaulių bankas (+1.69%) käibega 161 tuhat eurot ja tehingute arv oli 55. Tallinna Kaubamaja Grupp (0.00%) järgnes 74 tuhande euroga ning tehingute arv oli 34, mille hulgas oli üks plokktehing (EUR 9.620 x 2000). Tallink Grupp (-0.42%) aktsiaga tehti 30 tehingut kogumahus 47 tuhat.

    Suurimad tõusjad olid Pieno žvaigždės (+3.39%, käive EUR 3k), PRFoods (+2.94%, käive EUR 6k), SAF Tehnika (+2.68%, käive EUR 19k). Ainsad langejad olid Nordecon (-0.83%, käive EUR 4k), LHV Group (-0.44%, käive EUR 30k), Tallink Grupp (-0.42%, käive EUR 47k).

    Täna:
    LHV Group finantsplaani avalikustamine
  • Volatiilsus püsib aktsiaturgudel kõrgena, kuid Ühendriikides suudeti siiski hoida meeleolu positiivsena ning jätkata reedest põrget (S&P 500 +1,4%). Euroopas taastus Stoxx 600 suurimast nädalasest kukkumisest alates 2016. aastast, kerkides 1,2%.

    Erinevalt finantsturgude ootusest, et USA inflatsioon tõstab lähitulevikus pead, näitas NY FEDi värske küsitlus, et tarbijate hinnatõusu ootused on tulnud jaanuaris alla. Ühe aasta mediaanootus alanes 2,82% pealt 2,71%le ning kolme aasta ootus 2,89% pealt 2,79%le. Chicago FEDi president Charles Evans tõi eelmisel nädalal välja, et tarbijate inflatsiooniootus on tegeliku inflatsiooni puhul võtmetähendusega, sest sellel baseerub palganõudlus ning ettevõtete toodete ja teenuste hinnastamise otsus. Suurt tähtsust omistas tarbijate inflatsiooniootustele ka St. Louis FEDi president James Bullard, kelle arvates saadavad need tuleviku inflatsiooni kohta paremat signaali kui madal töötuse määr.



    USA valitsuse eelarve ülejäägiks kujunes jaanuaris 49,2 miljardit dollarit, mis oli ligilähedane analüütikute prognoositud 51,0 miljardile dollarile. Oktoobris alanud fiskaalaasta puudujääk ulatus jaanuari lõpuks -175,7 miljardi dollarini, kasvades eelmise aasta sama perioodiga võrreldes 11%.



    Majandusuudiste valik jääb tagasihoidlikuks ka täna, kui mainimist vääriksid vaid Suurbritannia jaanuari inflatsioon ning USA väikefirmade jaanuari kindlustunde indeks.

    11.30 Suurbritannia inflatsioon (jaanuar)
    13.00 USA väikefirmade kindlustunde indeks (jaanuar)
    15.00 FEDi Mester esineb
  • Suurbritannia alusinflatsioon kiirenes jaanuaris 0,2pp võrra 2,7% peale ehk veidi rohkem kui oodatud 2,6%
  • USA väikefirmade kindlustunde indeks põrkas jaanuaris kahe punkti võrra 106,9 punktile (oodati 105,3), jõudes tagasi kõrgeima taseme lähedale alates 1983. aastast
  • Gapping up
    In reaction to strong earnings/guidance:


    WMIH +63.3%, GNC +36%, TYHT +29%, DAC +15.4%, UAA +12.4%, RNG +9.2%, QTNA +8.5%, WB +7.1%, VIPS +6.8%, APRN +6.3%, SREV +6.1%, (signs multi-year contract extensions with two long-standing technology clients), VECO +4.6%, DBD +4.5%, VRNS +3.9%, QLYS +3.4%, CHGG +3.3%, NRZ +3.2%, SQNS +2.6%, DNB +2.1%, FMC +2%, AMKR +1.3%, BRX +1.2%, ONDK +1.1%, AB +1%
    M&A news:

    CRVP +22.2% (Cott announces agreement to acquire Crystal Rock Holdings for approx $35 mln)
    ABC +12.3% (AmerisourceBergen: Walgreens (WBA) has made an offer to acquire ABC, according to WSJ)
    HDNG +8.3% (Hardinge to be acquired by Privet Fund Management for $18.50 per share in cash)
    Other news:

    VRTX +3.3% (announces FDA approval of FDA SYMDEKO to treat the underlying cause of Cystic Fibrosis in people ages 12 and older with certain mutations in the CFTR gene-to begin shipping to pharmacies this week)
    CBIO +2.9% (announces proposed public offering of common stock)
    DNR +2.9% (reports Q4 production was 61,144 barrels of oil equivalent per day; 2018 development capital budget is $300-325 million)
    CLLS +2.6% (granted 2 patents for CRISPR Use in T-Cells in the US)
    GRA +0.6% (CEO/Chairman discloses the purchase of 25k shares)
    Analyst comments:

    CBAY +6.1% (initiated with a Outperform at Evercore ISI)
    ICHR +4.6% (upgraded to Strong Buy from Buy at Needham)
    ADT +4.1% (initiated with a Buy at Goldman, among others)
    NTAP +3% (upgraded to Buy from Neutral at BofA/Merrill; upgraded to Buy from Hold at Loop Capital)
    ADI +1.7% (upgraded to Overweight from Neutral at Piper Jaffray)
    NINE +1.7% (initiated with a Overweight at JP Morgan; initiated with a Buy at BofA/Merrill)
    FRAC +1.4% (upgraded to Buy from Neutral at Citigroup)
    HIIQ +1.1% (initiated with a Buy at B. Riley FBR)
    CELG +1% (upgraded to Overweight from Equal Weight at Barclays)
    MMM +0.9% (upgraded to Buy from Hold at Deutsche Bank)
    TOT +0.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley; upgraded to Strong Buy at Raymond James)
    Gapping down
    In reaction to disappointing earnings/guidance:


    NVTA -4.5%, MOH -4.1%, NVMI -2.3%, G -1.9%, PEP -0.5%
    Other news:

    DARE -31.2% (announces intent to offer primary shares of its common stock and warrants to purchase shares of its common stock)
    HMNY -20.5% (commences best efforts underwritten public offering to issue and sell shares of its common stock and warrants to purchase shares of its common stock; size not disclosed)
    AFMD -8.2% (commences an underwritten public offering of its common shares)
    HSIC -6.5% (Federal Trade Commission filed a complaint against the nation's three largest dental supply companies)
    PDCO -5.7% (Federal Trade Commission filed a complaint against the nation's three largest dental supply companies)
    PACB -3.9% (commences common stock offering)
    GLUU -1.9% (pulling back after 13% move higher)
    TEVA -1.9% (trading lower in response after NVS received FDA approval for Glatopa)
    COGT -1.7% (announced its plan to spin-off its data and analytics business, Red Violet, earlier than previously anticipated)
    Analyst comments:

    N/A.

    Briefing.com
  • Cleveland FEDi president Loretta Mester jääb senisele intressimäära prognoosile truuks ega kiirusta veel maksureformi mõjust mingeid pikaajalisi järeldusi tegema.

    *Federal Reserve Bank of Cleveland President Loretta Mester says tax cuts have added upside risks to her outlook for the U.S. economy, but a gradual pace of interest- rate increases still remains the correct course.
    * “While a deeper and more persistent drop in equity markets could dash confidence and lead to a pullback in risk-taking and spending, the movements we have seen are far away from this scenario,” Mester says in text of speech in Dayton, Ohio
    * Mester says trading has remained orderly and markets “generally liquid,” with no pullback in credit
    * “I think that there’s more salient upside risks to the forecast than we’ve seen in quite a while. I think that it’s going to be important to evaluate how firms and households are responding to the tax cuts”: Mester
    * Mester speaks with reporters after giving speech in Dayton, Ohio
    * “I put a quarter to a half percentage point on extra growth from those over this year and next year -- given what I’ve seen so far in how people have said they’ve reacted to the tax cuts.
    I think it potentially could be bigger than that, so that’s an upside risk to the forecast”
    * On rate hikes, says “the gradual path is my modal forecast, but I do think we have to be very observant of how the economy is evolving”
    * “I expect the short-run neutral rate to move up over time as the expansion continues”
  • 13Fs will be released today and tomorrow after the bell.
    See info on muidugi eelmise kvartali kohta, kus oli kõik veel roosiline.

Teemade nimekirja